KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Deferred Taxes (2016 - 2025)

Evolent Health (EVH) has 11 years of Deferred Taxes data on record, last reported at -$3.0 million in Q4 2025.

  • For Q4 2025, Deferred Taxes fell 183.22% year-over-year to -$3.0 million; the TTM value through Dec 2025 reached -$3.0 million, changed 0.23%, while the annual FY2025 figure was -$3.0 million, 0.23% changed from the prior year.
  • Deferred Taxes reached -$3.0 million in Q4 2025 per EVH's latest filing, down from $627000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $777000.0 in Q4 2022 and bottomed at -$68.7 million in Q1 2023.
  • Average Deferred Taxes over 5 years is -$7.3 million, with a median of -$551500.0 recorded in 2021.
  • The widest YoY moves for Deferred Taxes: up 426.47% in 2022, down 234185.0% in 2022.
  • A 5-year view of Deferred Taxes shows it stood at -$238000.0 in 2021, then soared by 426.47% to $777000.0 in 2022, then crashed by 2037.97% to -$15.1 million in 2023, then surged by 92.87% to -$1.1 million in 2024, then crashed by 183.22% to -$3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were -$3.0 million in Q4 2025, $627000.0 in Q3 2025, and -$865000.0 in Q2 2025.